I don’t get what happened to $ESPR today : stocks
Esperion (ESPR) released a press release today stating that their phase 3 CLEAR study met its primary endpoint (mortality benefit ...
Esperion (ESPR) released a press release today stating that their phase 3 CLEAR study met its primary endpoint (mortality benefit ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.